2022–2023 mpox outbreak in Asia

Overview of the 2022–2023 mpox outbreak in Asia

The 2022–2023 mpox outbreak in Asia is part of the global 2022–2023 mpox outbreak, which saw a significant increase in cases of mpox (formerly known as monkeypox) outside of its traditional endemic regions in Africa. This outbreak has affected multiple countries across Asia, leading to public health responses and international collaboration to control the spread of the virus.

Background

Stages of monkeypox lesion development

Mpox is a viral zoonotic disease caused by the monkeypox virus, a member of the Orthopoxvirus genus. The disease is characterized by symptoms similar to those of smallpox, though generally less severe. The virus is transmitted to humans through close contact with an infected person or animal, or with material contaminated with the virus.

The 2022–2023 outbreak marked the first time mpox spread widely outside of Africa, with cases reported in Europe, the Americas, and Asia. The outbreak prompted the World Health Organization (WHO) to declare a public health emergency of international concern.

Outbreak in Asia

Spread of 2022 monkeypox outbreak in Asia

The outbreak in Asia began in mid-2022, with the first cases reported in countries such as Israel, United Arab Emirates, and India. The spread of the virus in Asia was facilitated by international travel and close contact among individuals in densely populated areas.

Affected Countries

Israel

Israel was one of the first countries in Asia to report cases of mpox. The Israeli Ministry of Health implemented measures to contain the outbreak, including contact tracing and vaccination campaigns targeting high-risk populations.

United Arab Emirates

The United Arab Emirates reported its first case of mpox in May 2022. The country took swift action to isolate cases and prevent further transmission, including public awareness campaigns and enhanced surveillance at points of entry.

India

India confirmed its first case of mpox in July 2022. The Indian government issued guidelines for the management of mpox cases and initiated a vaccination program for healthcare workers and other vulnerable groups.

Other Countries

Other countries in Asia, including Thailand, Singapore, and Japan, also reported cases of mpox. These countries implemented various public health measures to control the outbreak, such as quarantine protocols and public education initiatives.

Public Health Response

The response to the mpox outbreak in Asia involved coordination between national health authorities and international organizations such as the WHO. Efforts focused on surveillance, vaccination, and public education to reduce transmission and protect vulnerable populations.

Vaccination

Vaccination played a crucial role in controlling the outbreak. Countries in Asia utilized smallpox vaccines, which provide cross-protection against mpox, to immunize healthcare workers and high-risk groups.

Public Awareness

Public awareness campaigns were launched to educate the population about the symptoms of mpox, modes of transmission, and preventive measures. These campaigns aimed to reduce stigma and encourage individuals to seek medical attention if they exhibited symptoms.

Impact

The mpox outbreak in Asia had significant social and economic impacts. The outbreak strained healthcare systems and required substantial resources for containment efforts. Additionally, the outbreak highlighted the need for improved global surveillance and response mechanisms for emerging infectious diseases.

Related pages

• 2022–2023 mpox outbreak
• Monkeypox
• World Health Organization